Australia markets closed

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
78.900.00 (0.00%)
At close: 03:12PM EST
Full screen
Loading interactive chart…
  • Zacks

    Novartis (NVS) Highlights Growth Profile at its R&D Day

    Novartis (NVS) throws light on its pipeline progress, key areas of focus and long-term targets at its R&D day. Here, we discuss key highlights from the same.

  • Zacks

    Aurinia (AUPH) Stock Up on Potential Acquisition Rumors

    Aurinia (AUPH) gains on rumors of a potential acquisition yet again. Reportedly, the company is being eyed by Novartis.

  • Motley Fool

    Why Aurinia Pharmaceuticals Stock Bolted Higher Today

    Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by a noteworthy 15.5% as of 1:10 p.m. ET Thursday afternoon. Rumors began to swirl about a possible buyout this morning after Novartis (NYSE: NVS) reportedly said during its research and development day that it will focus on smaller bolt-on acquisitions, instead of megadeals. Aurinia has repeatedly been the topic of the buyout rumor mill in 2021.